NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free PDEX Stock Alerts $17.55 +0.14 (+0.80%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$17.41▼$17.7150-Day Range$16.50▼$22.5052-Week Range$14.51▼$22.99Volume2,303 shsAverage Volume8,390 shsMarket Capitalization$61.60 millionP/E Ratio23.40Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Pro-Dex alerts: Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About Pro-Dex Stock (NASDAQ:PDEX)Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Read More PDEX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDEX Stock News HeadlinesMarch 26, 2024 | americanbankingnews.comPro-Dex (NASDAQ:PDEX) Stock Passes Below Two Hundred Day Moving Average of $17.60March 15, 2024 | seekingalpha.comMonogram Orthopaedics reports FY resultsMarch 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.February 22, 2024 | finance.yahoo.comThe Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire ConfidenceFebruary 8, 2024 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month ResultsJanuary 26, 2024 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five yearsDecember 30, 2023 | finance.yahoo.comIs Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?November 14, 2023 | finance.yahoo.comHere’s Why You Should Consider Buying Pro-Dex (PDEX) SharesMarch 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.November 10, 2023 | morningstar.comPro-Dex Inc PDEXNovember 2, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsNovember 2, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000October 26, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastOctober 26, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastOctober 15, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 13, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 4, 2023 | morningstar.comNorth American Morning Briefing: S&P 500 Futures -2-August 7, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns Have Hit A WallJune 29, 2023 | finance.yahoo.comAt US$18.26, Is It Time To Put Pro-Dex, Inc. (NASDAQ:PDEX) On Your Watch List?June 5, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastJune 5, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastMay 30, 2023 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 23% CAGR over the last five yearsMay 4, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month ResultsApril 20, 2023 | seekingalpha.comPDEX Pro-Dex, Inc.March 31, 2023 | finance.yahoo.comOne Pro-Dex, Inc. (NASDAQ:PDEX) insider upped their stake by 36% in the previous yearFebruary 27, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns On Capital Not Reflecting Well On The BusinessFebruary 14, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 2nd Quarter Results and 2023 Growth Strategy with The Stock Day PodcastSee More Headlines Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2024Today3/28/2024Next Earnings (Estimated)5/02/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:PDEX CUSIPN/A CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees145Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.75 Trailing P/E Ratio23.47 Forward P/E RatioN/A P/E GrowthN/ANet Income$7.07 million Net Margins5.59% Pretax Margin8.28% Return on Equity8.97% Return on Assets5.40% Debt Debt-to-Equity Ratio0.26 Current Ratio3.66 Quick Ratio2.16 Sales & Book Value Annual Sales$46.09 million Price / Sales1.34 Cash Flow$2.29 per share Price / Cash Flow7.69 Book Value$8.91 per share Price / Book1.98Miscellaneous Outstanding Shares3,510,000Free Float2,015,000Market Cap$61.78 million OptionableNot Optionable Beta0.60 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Richard Lee Van Kirk Jr. (Age 63)CEO, President, COO & Director Comp: $418.61kMs. Alisha K. Charlton (Age 54)CFO & Corporate Secretary Comp: $297.61kKey CompetitorsBeyond AirNASDAQ:XAIRGBSNYSE:GBSCarmellNASDAQ:CTCXSensus HealthcareNASDAQ:SRTSInspireMDNYSE:NSPRView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 2,454 shares on 3/11/2024Ownership: 3.522%Vanguard Group Inc.Bought 2,454 shares on 2/15/2024Ownership: 3.523%Perritt Capital Management Inc.Bought 4,187 shares on 2/15/2024Ownership: 0.119%Northern Trust CorpBought 6,141 shares on 2/13/2024Ownership: 0.738%LSV Asset ManagementSold 5,800 shares on 2/6/2024Ownership: 0.729%View All Institutional Transactions PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed in 2024? Pro-Dex's stock was trading at $17.52 at the start of the year. Since then, PDEX stock has increased by 0.2% and is now trading at $17.55. View the best growth stocks for 2024 here. Are investors shorting Pro-Dex? Pro-Dex saw a increase in short interest in March. As of March 15th, there was short interest totaling 18,600 shares, an increase of 34.8% from the February 29th total of 13,800 shares. Based on an average trading volume of 8,200 shares, the short-interest ratio is currently 2.3 days. Currently, 0.8% of the shares of the stock are short sold. View Pro-Dex's Short Interest. When is Pro-Dex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our PDEX earnings forecast. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) released its quarterly earnings data on Thursday, February, 8th. The medical instruments supplier reported $0.14 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $12.59 million for the quarter. Pro-Dex had a trailing twelve-month return on equity of 8.97% and a net margin of 5.59%. What is Michael J. Berthelot's approval rating as Pro-Dex's CEO? 3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH). Who are Pro-Dex's major shareholders? Pro-Dex's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.52%), Vanguard Group Inc. (3.52%), Northern Trust Corp (0.74%), LSV Asset Management (0.73%) and Perritt Capital Management Inc. (0.12%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp and William James Farrell III. View institutional ownership trends. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PDEX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the MarketsBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.